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Abstract: Two new pyrazoline derivatives, 3,5-bis(4-fluorophenyl)-4,5-dihydropyrazole-
1-carboxamide (1) and 3,5-bis(4-fluorophenyl)-4,5-dihydropyrazole-1-carbothioamide (2), 
were synthesized by reacting 4,4'-difluoro chalcone with semicarbazide hydrochloride and 
thiosemicarbazide in ethanolic sodium hydroxide solution. Both the compounds were 
confirmed by single crystal X-ray diffraction data and supported by IR, NMR, and mass 
spectral data. In 1, crystal packing is stabilized by N–H…O hydrogen bonds and weak  
N–H...N, N–H…F and C–H…F intermolecular interactions. In 2, only weak N–H…F and 
N–H…S intermolecular interactions are observed. Crystal data: C16H13F2N3O, (1),  
Mr = 301.29, monoclinic, C2/c, a = 17.6219(6) Å, b = 10.8735(3) Å, c = 15.3216(5) Å,  
β = 102.864(3)°, V = 2862.11(16) Å3, Z = 8, T = 173 K, R(F) = 0.0511, wR(F2) = 0.1333; 
C16H13F2N3S, (2), Mr = 317.35, monoclinic, P21/c, a = 14.339(2) Å, b = 11.1478(17) Å,  
c = 9.541(2)(5) Å, β = 107.007(18)°, V = 1458.5(5) Å3, Z = 4, T = 173 K, R(F) = 0.0413, 
wR(F2) = 0.0959.  
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Pyrazolines are well known, and important nitrogen-containing five-membered heterocyclic 
compounds and various methods have been reported for their synthesis [1,2]. Substituted pyrazolines 
are useful in pharmaceutical and agrochemical research. They display various biological activities such 
as antitumor, antibacterial, antifungal, antiviral, antiparasitic, anti-tubercular and insecticidal [3–5]. 
Some of these compounds have also antioxidant, anti-inflammatory and analgesic properties [6,7]. Due 
to these interesting activities of diversely substituted pyrazolines as biological agents, considerable 
attention has been focused on this class. In addition, pyrazolines have played a crucial part in the 
development of the theory in heterocyclic chemistry and also used extensively in organic synthesis [8].  
Crystal structures of some 3,5-diaryl-4,5-dihydropyrazoles substituted at position 1 with 
carboxamide or carbothioamide groups, viz., 4,5-dihydro-3-methyl-5-(4-methylphenyl)-1H-pyrazole-
1-carboxamide [9] and 3-(4-bromophenyl)-5-[4-(dimethylamino)phenyl]-4,5-dihydro-1H-pyrazole-1-
carbothioamide [10] have been reported. 
In view of the importance of pyrazolines and in continuation of our work on synthesis of various 
derivatives of 4,4'-difluoro chalcones [11–18], we report the synthesis and crystal structures of new 
3,5-bis(4-fluorophenyl)-4,5-dihydropyrazoles substituted at position 1 with carboxamide or 
carbothioamide groups (Figure 1). 
Figure 1. The molecular structures of (1) C16H13F2N3O and (2) C16H13F2N3S. 
  
(1)                                                                    (2) 
2. Results and Discussion 
The IR spectrum of compound 1 (Figure S1) showed a forked band at 3452 cm−1 corresponding to 
NH2 group and a band at 1681 cm−1 assigned to the carbonyl group. While, the IR spectrum of 
compound 2 (Figure S2) demonstrated a forked band at 3475 cm−1 corresponding to a NH2– group and 
a band at 1365 cm−1 corresponding to a C=S group. The IR spectra of both the compounds showed a  
–C=N–stretch at 1577 & 1599 cm−1, which confirmed the formation of the pyrazoline moiety. In the 
1H NMR spectra of pyrazolines (Figures S3 and S4), protons HA and HB are geminal protons at the  
C4 carbon. They appeared in the region 3.03–3.12 ppm and 3.75–3.84 ppm as a doublet of doublets for 
both the compounds. The CH proton at C5 also appeared as a doublet of doublets in the region of 
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5.38–5.89 ppm, due to vicinal coupling with two non-equivalent geminal protons of the C4 carbon. 
Beside these signals, the amino protons appeared as broad singlet signal at δ 6.5 in compound 1 and as 
two singlet signals at δ 7.95 & 8.02 in compound 2. LCMS (Figures S5 and S6) and elemental analysis 
also gave satisfactory results for both of the compounds. 
In the crystal structures, the dihedral angle between the pyrazole ring and the two benzene rings is 
1.9(1) Å and 55.9(6) Å in 1 (Figure 2) and 15.1(1) Å and 80.9(8) Å in 2 (Figure 3), respectively.  
Figure 2. Molecular structure of 1 showing the atom labeling scheme and 50% probability 
displacement ellipsoids. 
 
Figure 3. Molecular structure of 2 showing the atom labeling scheme and 50% probability 
displacement ellipsoids. 
 
Bond lengths are in normal ranges for 1 and 2 [19]. Selected bond lengths and angles for both 
molecules are listed in Table 1.  
Table 1. Selected atom distances [Å] for 1 and 2. 
Atoms 1 Distance 1 Atoms 2 Distance 2 
C1—O1 1.2300(19) C1—S1 1.6818(16) 
C1—N1 1.340(2) C1—N1 1.331(2) 
N2—N3 1.3929(17) N2—N3 1.3924(17) 
N2—C2 1.4754(19) N2—C2 1.4761(19) 
N3—C4 1.2804(19) N3—C4 1.283(2) 
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Table 1. Cont. 
Atoms 1 Distance 1 Atoms 2 Distance 2 
C2—C3 1.544(2) C2—C3 1.538(2) 
C3—C4 1.498(2) C3—C4 1.501(2) 
C8—F1 1.358(2) C8—F1 1.356(2) 
C14—F2 1.3658(18) C14—F2 1.3665(19) 
In 1, the molecules in the crystal form an inversion dimer through a pair of N–H…O, hydrogen 
bonds. These dimers are further linked through weak N–H…F and C–H…F intermolecular interactions 
(Table 2) into a sheet-like structure in the ac-plane (Figure 4). In addition, weak π—π intermolecular 
interactions (Cg1…Cg2; 3.9841(11) Å; 1 − x, 1 − y, 1 − z, and Cg1…Cg3; 3.8319(9) Å, x, y, z where  
Cg1 = centroid for N2/N3/C4/C3/C2, Cg2 = centroid for C5—C10, Cg3 = centroid for C11—C16) are 
observed which help stabilize crystal packing.  
Table 2. Hydrogen bonds for 1, C16H13F2N3O [Å and °]. 
D–H...A d (D–H) d (H...A) d (D...A) < (DHA) 
N1–H1NA...O1 #1 0.88(2) 2.06(2) 2.928(2) 171(2) 
N1–H1NB...F2 #2 0.88(2) 2.38(2) 3.129(2) 143(2) 
C13–H13A...F1 #3 0.93 2.54 3.386(2) 151 
Symmetry transformations used to generate equivalent atoms: #1 –x + 1, −y + 2, −z + 1; #2 x − 1/2, 
−y + 3/2, z − 1/2; #3 –x + 1, y + 1, −z + 3/2.  
Figure 4. Packing diagram of 1 viewed along the b axis. Dashed lines indicate N–H...O 
hydrogen bonds forming an inversion dimer. Additional weak N–H…F and C–H…F 
intermolecular interactions further link the molecules into a sheet-like structure in the  
ac-plane. Remaining H atoms have been removed for clarity. 
 
Crystals 2012, 2             1112 
 
In 2, N–H…F and N–H…S hydrogen bonds are observed creating an infinite 1-D chain along (001) 
which along with weak C–H…Cg π–ring intermolecular interactions (Table 3) strongly influence 
crystal packing (Figure 5).  
Table 3. Hydrogen bonds for 2, C16H13F2N3S [Å and °]. 
D–H...A d (D–H) d (H...A) d (D...A) < (DHA) 
N1–H1NB...F2#1 0.87(2) 2.41(2) 3.258(2) 164(2) 
N1–H1NA...S1#2 0.84(2) 2.85(2) 3.525(2) 138(2) 
Symmetry transformations used to generate equivalent atoms: #1 x, y, z−1; #2 x, −y + 3/2,  
z − 1/2. 
Figure 5. Packing diagram of 2 viewed along the b axis. Dashed lines indicate N–H...F and 
N–H...S hydrogen bonds forming chains along (001). Remaining H atoms have been 
removed for clarity. 
 
3. Experimental Section 
3.1. General 
The synthesis of the target compounds is outlined in Scheme 1. 4,4'-Difluoro chalcone  was reacted 
with semicarbazide HCl or thiosemicarbazide in ethanolic NaOH to afford  
3,5-bis(4-fluorophenyl)-4,5-dihydropyrazole-1-carboxamide (1) and 3,5-bis(4-fluorophenyl)-4,5-
dihydropyrazole-1-carbothioamide (2) respectively. 












1:  X = O
2:  X = S  
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Melting points were taken in open capillary tubes and were uncorrected. The purity of the 
compounds was confirmed by thin layer chromatography using Merck silica gel 60 F254 coated 
aluminum plates. IR spectra were recorded on Shimadzu-FTIR Infrared spectrometer in KBr  
(mmax in cm−1). 1H (400 MHz) NMR spectra were recorded on a Bruker AMX 400 spectrometer, with 
5 mm PABBO BB −1H TUBES with TMS as internal standard. LCMS was obtained using Agilent 
1200 series LC and Micromass zQ spectrometer. Elemental analyses were carried out by using VARIO 
EL-III (Elementar Analysensysteme GmBH). 
3.2. Synthesis of 3,5-Bis(4-fluorophenyl)-4,5-dihydro-1H-pyrazole-1-carboxamide (1) 
A mixture of 4,4'-difluoro chalcone (1.22 g, 0.005 mol), semicarbazide HCl (0.6 g, 0.005 mol) and 
NaOH (0.5 g, 0.0125 mol) was heated under reflux in absolute ethanol (12.5 mL) for 12 h. The 
reaction mixture was cooled and poured into ice cold water. The solid separated was filtered, dried and 
recrystallized from ethanol. The single crystals were grown from DMF by slow evaporation method 
and yield of the compound was 78%. (m.p. 435 K). 
IR (KBr, cm−1): 3452, 3211 (NH2), 1681 (C=O), 1599 (C=N), 1224 (C–F); 1H NMR (400 MHz, DMSO) 
δ ppm 3.03 (dd, 1H, HA, J = 5.2 Hz,), 3.75 (dd, 1H, HB, J = 12 Hz), 5.38 (dd, 1H, HX, J = 5.60 Hz), 
6.50 (br s, 2H, NH2), 7.11–7.85 (m, 8H, Ar–H); LCMS: m/z 301.9 (M+); Analytical data: Found (Cald): 
C%: 63.72 (63.78); H%: 4.34 (4.35); N%: 13.91 (13.95). 
3.3. Synthesis of 3,5-Bis(4-fluorophenyl)-4,5-dihydro-1H-pyrazole-1-carbothioamide (2) 
A mixture of 4,4'-difluoro chalcone (1.22 g, 0.005 mol), thiosemicarbazide (0.46 g, 0.005 mol) and 
NaOH (0.5 g, 0.0125 mol) was heated under reflux in absolute ethanol (12.5 mL) for 16 h. The 
reaction mixture was cooled and poured into ice cold water. The solid separated was filtered, dried and 
recrystallized ethanol. The single crystals were grown from DMF by slow evaporation method and 
yield of the compound was 72%. (m.p. 526 K).  
IR (KBr, cm−1): 3475, 3354 (NH2), 1577 (C=N), 1365 (C=S), 1213 (C–F). 1H NMR (400 MHz, DMSO) 
δ ppm 3.12 (dd, 1H, HA, J = 3.6 Hz), 3.84 (dd, 1H, HB, J = 11.6 Hz), 5.89 (dd, 1H, HX, J = 3.6 Hz), 
7.11–7.94 (m, 8H, Ar–H), 7.95 & 8.02 (two s, 2H, NH2); LCMS: m/z 317.9 (M+); Analytical data: 
Found (Cald): C%: 60.52 (60.55); H%: 4.15 (4.13); N%: 13.22 (13.24). 
3.4. Data Collection and Refinement 
Crystallographic data for both 1 and 2 were collected on an Agilent Gemini CCD-Diffractometer 
with monochromatic Mo-Kα radiation (λ = 0.71073 Å) and an EOS detector [20]. The structures were 
solved by direct methods [21], full-matrix least-squares refinement [21] on F2 with 313 1 or 219 2 
parameters. In both 1 and 2, H1NA, and H1NB, were located in a difference map and refined 
isotropically. All of the remaining H atoms were placed in their calculated positions and then refined 
using the riding model with C–H lengths of 0.93 or 0.98 Å (CH) or 0.97 Å (CH2). The isotropic 
displacement parameters for these atoms were set to 1.19 to 1.20 (CH, CH2), times Ueq of the  
parent atom. 
Crystal data for 1: colorless chunk, 0.22 × 0.21 × 0.20 mm, C16H13F2N3O, Mr = 301.29, monoclinic 
C2/c, a = 17.6219(6) Å, b = 10.8735(3) Å, c = 15.3216(5) Å, β = 102.864(3)° and V = 2862.11(16) Å3, 
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Z = 8, F(000) = 1248, T = 173(2) K, ρcalc = 1.398 g·cm−3, μ = 0.108 mm−1, 12815 reflections measured 
(−22 ≤ h ≤ 23, −14 ≤ k ≤ 13, −20 ≤ l ≤ 19; 3.2974 ≤ θ ≤ 32.3351), Rint = 0.0220, 3684 merged 
reflections, I > 2σ(I), 205 parameters, 2 restraints, GOF = 1.011, R(F) = 0.0511, wR(F2) = 0.1333,  
w = 1/σ2(Fo2) + 0.0541P2, where P = (Fo2 + 2Fc2)/3, min./max. ∆ρ = −0.38, +0.37 e Å3. Cambridge 
Database deposition number: CSD-888442. 
Crystal data for 2: colorless chunk, 0.20 × 0.16 × 0.12 mm, C16H13F2N3S, Mr = 317.35, monoclinic 
P21/c, a = 14.339(2) Å, b = 11.1478(17) Å, c = 9.541(2) Å, β = 107.007(18)° and V = 1458.5(5) Å3,  
Z = 4, F(000) = 656, T = 173(2) K, ρcalc = 1.445 g·cm−3, μ = 0.243 mm−1, 13239 reflections measured 
(−18 ≤ h ≤ 18, −14 ≤ k ≤ 14, −11 ≤ l ≤ 12; 2.9651 ≤ θ ≤ 30.0998), Rint = 0.0331, 3483 merged 
reflections, I > 2σ(I), 205 parameters, 2 restraints, GOF 1.004, R(F) = 0.0413, wR(F2) = 0.0959,  
w = 1/σ2(Fo2) + 0.0541P2, where P = (Fo2 + 2Fc2)/3, min./max. ∆ρ = −0.216, +0.213 e Å3. Cambridge 
Database deposition number: CSD-888534. 
4. Conclusions  
The crystal and molecular structures of 3,5-bis(4-fluorophenyl)-4,5-dihydro-1H-pyrazole-1-
carboxamide (1) and 3,5-bis(4-fluorophenyl)-4,5-dihydro-1H-pyrazole-1-carbothioamide (2), and 
spectroscopic supporting data are reported. These data represent crystallographically characterized 
compounds of two new pyrazoline derivatives which are potentially useful in pharmaceutical and 
agrochemical research. The effects of hydrogen bonding and weak intermolecular interactions 
observed in both molecules influence crystal packing as described. 
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